federal_register: 2016-17008

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2016-17008 Pre-Clinical Evaluation of Red Blood Cells for Transfusion; Public Workshop Notice The Food and Drug Administration (FDA) is announcing a public workshop entitled "Pre-Clinical Evaluation of Red Blood Cells for Transfusion." The purpose of the public workshop is to discuss new methodologies for pre-clinical evaluation of the safety and efficacy of red blood cell transfusion products. The workshop has been planned in partnership with the National Heart, Lung, and Blood Institute; National Institutes of Health (NIH); the Department of Defense; and the Office of the Assistant Secretary for Health, Department of Health and Human Services. The workshop will include presentations and panel discussions by experts from academic institutions, industry, and government Agencies. 2016-07-19 2016 7 https://www.federalregister.gov/documents/2016/07/19/2016-17008/pre-clinical-evaluation-of-red-blood-cells-for-transfusion-public-workshop https://www.govinfo.gov/content/pkg/FR-2016-07-19/pdf/2016-17008.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is announcing a public workshop entitled "Pre-Clinical Evaluation of Red Blood Cells for Transfusion." The purpose of the public workshop is to discuss new methodologies for pre-clinical evaluation of the safety...  

Links from other tables